137 related articles for article (PubMed ID: 16295807)
21. [Prevention of osteoporosis and its economic aspects].
Blachier C
Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
[TBL] [Abstract][Full Text] [Related]
22. [Bone mineral density measurements for diagnosis of osteoporosis and the risk assessment].
Kushida K
Clin Calcium; 2004 Dec; 14(12):11-7. PubMed ID: 15577168
[TBL] [Abstract][Full Text] [Related]
23. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
24. [A good combination to achieve a reduced number of fractures: bone density measurements, drug therapy and hip protector].
Johnell O; Ljunggren O; Mellström D
Lakartidningen; 2001 Jul; 98(28-29):3204-6. PubMed ID: 11496807
[No Abstract] [Full Text] [Related]
25. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
26. [Osteoporosis: its diagnosis, its consequences].
Hardouin P
Rev Stomatol Chir Maxillofac; 1997 Nov; 98 Suppl 1():93-5. PubMed ID: 9471709
[TBL] [Abstract][Full Text] [Related]
27. [Osteoporosis--what is being done in Norway 1996?].
Falch JA
Nord Med; 1996 Dec; 111(10):339. PubMed ID: 8992464
[No Abstract] [Full Text] [Related]
28. [Talalgia caused by fluorine during the treatment of osteoporosis].
Marcelli C; Claustre JE; Pansard E; Herisson C; Simon L
Rev Rhum Mal Osteoartic; 1989; 56(8-9):597-600. PubMed ID: 2814298
[No Abstract] [Full Text] [Related]
29. The treatment of osteoporosis. Antiresorptive therapy.
Miller PD
Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiology of osteoporosis].
Grazio S
Reumatizam; 2006; 53(2):18-31. PubMed ID: 17580550
[TBL] [Abstract][Full Text] [Related]
31. [Primary health care should take the initiative in fighting osteoporosis].
Blivik J
Lakartidningen; 2002 Feb; 99(9):876-81. PubMed ID: 11962007
[No Abstract] [Full Text] [Related]
32. Prevention and treatment of osteoporosis in women with breast cancer.
Mincey BA; Moraghan TJ; Perez EA
Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
[TBL] [Abstract][Full Text] [Related]
33. Calcium and vitamin D in the prevention and treatment of osteoporosis.
Orcel P
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):70S-74S. PubMed ID: 9273942
[No Abstract] [Full Text] [Related]
34. [Osteobor forte--rational solution in fight against osteoporosis].
Petrova I
Akush Ginekol (Sofiia); 2003; 42 Suppl 2():39-40. PubMed ID: 14619756
[No Abstract] [Full Text] [Related]
35. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
Miller RG
Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
[TBL] [Abstract][Full Text] [Related]
36. Prevention and treatment of postmenopausal osteoporosis.
Lewiecki EM
Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis and bone mineral density.
Siaw EA; Vanderford V
Radiol Technol; 2001; 72(4):383-6. PubMed ID: 11269825
[No Abstract] [Full Text] [Related]
38. Osteoporosis prevention and the orthopaedic surgeon: when fracture care is not enough.
Freedman KB
J Bone Joint Surg Am; 1999 Nov; 81(11):1652-3. PubMed ID: 10565654
[No Abstract] [Full Text] [Related]
39. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of osteoporosis with antiresorptive drugs].
Vestergaard P; Mosekilde L; Brixen K
Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
